References
- LiesegangTJForsterRKSpectrum of microbial keratitis in South FloridaAm J Ophthalmol19809038477395957
- GopinathanUSharmaSGargPRaoGNReview of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decadeIndian J Ophthalmol20095727327919574694
- IyerSATuliSSWagonerRCFungal keratitis: emerging trends and treatment outcomesEye Contact Lens20063226727117099386
- GowerEWKeayLJOechslerRATrends in fungal keratitis in the United States, 2001 to 2007Ophthalmology20101172263226720591493
- GopinathanUGargPFernandesMSharmaSAthmanathanSRaoGNThe epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South IndiaCornea20022155555912131029
- RitterbandDCSeedorJAShahMKKoplinRSMcCormickSAFungal keratitis at the new york eye and ear infirmaryCornea20062526426716633023
- LohARHongKLeeSMannisMAcharyaNRPractice patterns in the management of fungal corneal ulcersCornea20092885685919654533
- FlorcruzNVPeczonIJrMedical interventions for fungal keratitisCochrane Database Syst Rev2008CD00424118254043
- HariprasadSMMielerWFLinTKSponselWEGraybillJRVoriconazole in the treatment of fungal eye infections: a review of current literatureBr J Ophthalmol20089287187818577634
- O’DayDMHeadWSAdvances in the management of keratomycosis and Acanthamoeba keratitisCornea20001968168711009320
- JurkunasUVLangstonDPColbyKUse of voriconazole in the treatment of fungal keratitisInt Ophthalmol Clin200747475917450006
- PandaAAhujaRBiswasNRSatpathyGKhokharSRole of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitisCornea20032213814112605049
- ThakarMOral fluconazole therapy for keratomycosisActa Ophthalmol (Copenh)1994727657677747592
- AgarwalPKRoyPDasABanerjeeAMaityPKBanerjeeAREfficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary studyIndian J Ophthalmol20014917317615887725
- MohanMGuptaSKKalraVKVajpayeeRBSachdevMSTopical silver sulphadiazine–a new drug for ocular keratomycosisBr J Ophthalmol1988721921953281706
- RahmanMRJohnsonGJHusainRHowladerSAMinassianDCRandomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in BangladeshBr J Ophthalmol1998829199259828778
- PrajnaNVJohnRKNirmalanPKLalithaPSrinivasanMA randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitisBr J Ophthalmol2003871235123714507756
- KalavathyCMParmarPKaliamurthyJComparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitisCornea20052444945215829804
- MahdyRANadaWMWagehMMTopical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosisJ Ocul Pharmacol Ther20102628128520565316
- PrajnaNVMascarenhasJKrishnanTComparison of natamycin and voriconazole for the treatment of fungal keratitisArch Ophthalmol201012867267820547942
- AroraRGuptaDGoyalJKaurRVoriconazole versus natamycin as primary treatment in fungal corneal ulcersClin Experiment Ophthalmol2010In press.
- PfallerMADiekemaDJGibbsDLResults from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusionJ Clin Microbiol2010481366137720164282